medicines
-
1-Jun-2017 Focus on the Global South
Civil society interventions on the RCEP
In the recent “RCEP 18th Round of Talks,” members of civil society organizations and social movements presented their positions vis-à-vis the RCEP.
-
30-May-2017 MSF
MSF response on the India-EFTA free trade agreement negotiations in Liechtenstein this week
Through this deal, Swiss pharmaceutical corporations are working to erode India’s ability to produce and supply generic medicines for people across the developing world.
-
18-May-2017 Inquirer.net
Why RCEP is the problem, not the solution
RCEP negotiations have been highly conspiratorial and undemocratic, with all 18 rounds of trade discussions held in secret and no reports shared with the public
-
12-May-2017 GABRIELA Philippines
Women’s intervention at the RCEP TNC 18th round stakeholders’ meeting in Philippines
The RCEP will only further marginalize women
-
12-May-2017 People Over Profit
Protests mark RCEP Manila rounds
#NoRCEP week of actions at the 18th TNC Meeting of the Regional Comprehensive Economic Partnership
-
11-May-2017 Trade Justice Pilipinas
Reject RCEP and reject unjust trade deals
Trade Justice Pilipinas expresses its opposition to the Regional Comprehensive Economic Partnership agreement or RCEP
-
8-May-2017 MSF
MSF response on RCEP negotiations in the Philippines
Negotiators must protect public health safeguards that enable developing countries like India to keep supplying life-saving affordable medicines for millions of people worldwide.
-
8-May-2017 Forum on FTAs
Stop trading workers’ rights over profits
RCEP magnifies existing inequalities and discriminates against women, indigenous peoples, people living with HIV or other illnesses, people with disabilities,rural communities, farmers and workers
-
3-May-2017 Bez
La ratificación del CETA amenaza la salud de los españoles y el mantenimiento del SNS
Es necesario lamar la atención sobre la repercusión de CETA sobre los sistemas sanitarios y el acceso de los ciudadanos a los medicamentos.
-
3-May-2017 AFTINET
RCEP: Corporations could sue governments
ISDS is increasingly being used by global corporations to challenge health, environment and other public interest laws.
-
27-Apr-2017 Forum against FTAs
Employment crisis and free trade agreements( FTAs) : Why workers should reject RCEP
Trade unions, farmers groups, health activists, and other people’s movements are planning to organise a series of events to put pressure on the Government of India to withdraw from RCEP negotiations.
-
26-Apr-2017 The Hindu
The expanding universe of IP
Granting data exclusivity for clinical trials would undermine access to medicines.
-
25-Apr-2017 Canadian Lawyer
CETA bringing changes to pharma patents in Canada
A certificate of supplemental protection provides up to two years of additional protection after expiry of a patent.
-
13-Apr-2017 AGEFI
Novartis pointé du doigt en Colombie
Le géant bâlois est accusé d’avoir "menacé" le ministère colombien du Commerce et de l’Industrie de recourir à un tribunal d’arbitrage international.
-
12-Apr-2017 Public Eye
Compulsory licensing in Colombia: Leaked documents show aggressive lobbying by Novartis
Confidential documents obtained by Public Eye show that Novartis has threatened Colombia with international investment arbitration under its BIT with Switzerland to avoid the issuance of a compulsory license
-
5-Apr-2017 IA Reporter
Gilead Pharma corp withdraws investment arbitration after Ukraine agrees to settlement of dispute over monopoly rights to market anti-viral drug
Ukraine has settled a dispute with American pharmaceutical company Gilead Sciences Inc., following the company’s pursuit of legal remedies in both domestic courts and via investment arbitration.
-
29-Mar-2017 Scroll.in
Proposed trade pact clause on intellectual property could endanger India’s TB programme
A draft of the Regional Comprehensive Economic Partnership agreement reveals three clauses that could potentially hurt production of important generic drugs
-
27-Mar-2017 Lexology
Tribunal dismisses Eli Lilly’s NAFTA challenge on promise utility doctrine
The Tribunal found that Eli Lilly had failed to demonstrate that the promise doctrine constitutes a fundamental or dramatic change in the utility requirement under Canadian patent law or that the promise doctrine is arbitrary and/or discriminatory.
-
24-Mar-2017 IP Watch
What to watch out for in the EU-Mercosur FTA negotiations: consequences for access to medicines
Some of the main TRIPS-plus measures historically pushed for by countries such as the United States or the EU are being again proposed at the EU-Mercosur FTA.
-
23-Mar-2017 Scroll.in
Switzerland wants stricter intellectual property rules in India that could harm generic drug makers
Switzerland is pushing for tighter patent protection, data exclusivity and dropping compulsory licencing under a new free trade agreement.
News from the movements
-
19-Jun-2017 OMAL
Aprendizajes de las resistencias feministas latinoamericanas a los Tratados de Libre Comercio e Inversión
¿De qué manera afrontar este momento como feministas, como conjunto de movimientos sociales, como ciudadanía crítica? -
13-Jun-2017 Argentina Mejor sin TLC
Argentina: Encuentro Nacional Preparatorio para la Semana de Acción contra la OMC
Invitamos a todas las organizaciones y movimientos, agrupaciones, partidos y articulaciones de todas las provincias al Encuentro Nacional de Planificación contra la OMC en Argentina, que tendrá lugar el sábado 24 de Junio a partir de las 9.30 en el Aula HU 402 de la Facultad de Ciencias Sociales (UBA) en Santiago del Estero 1029, CABA -
6-Jun-2017 Tele Sur
Hundreds protest EU-Canada free trade deal in Madrid
People from over 400 trade unions and social organizations took part in the protest to demand that the Spanish Government block the free trade deal.
-
1-Jun-2017 Focus on the Global South
Civil society interventions on the RCEP
In the recent “RCEP 18th Round of Talks,” members of civil society organizations and social movements presented their positions vis-à-vis the RCEP. -
30-May-2017 No al TTIP
La plataforma No al TTIP, CETA, TiSA de Madrid convoca para la manifestación del 3J
Miembros de la campaña No al TTIP, CETA, TiSA de Madrid participan en un canutazo de prensa con los concejales de Ahora Madrid, Carlos Sánchez Mato, Rita Maestre y Pablo Carmona para apoyar la manifestación del próximo sábado 3 de junio en Madrid denunciando que el tratado comercio UE-Canadá (CETA) -
30-May-2017 Radio NZ
Pacific NGOs maintain opposition to PACER Plus
Dozens of civil society groups in the Pacific have reiterated their criticism of the PACER Plus trade deal, and said it is likely to fail the people of the Pacific. -
30-May-2017 MSF
MSF response on the India-EFTA free trade agreement negotiations in Liechtenstein this week
Through this deal, Swiss pharmaceutical corporations are working to erode India’s ability to produce and supply generic medicines for people across the developing world. -
29-May-2017 La Vía Campesina
Declaración de La Vía Campesina en contra del Acuerdo de Libre Comercio entre la UE y Japón
El ALC UE-Japón hará incrementar de forma significante las importaciones agrícolas, lo que causará un sufrimiento extremo en las familias campesinas. El acuerdo podría ir incluso más allá que el TPP, el peor acuerdo en cuanto a la destrucción agrícola.
bilaterals.org is a collaborative space to share information and support movements struggling against bilateral trade and investment deals which serve corporations, not people. Multilingual. Global. No one owns it. Open publishing. Get involved.